Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 24 Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 3 Gastrointestinal 3 Sarcoma 2 Plasma cell 2 Other 2 Breast 2 Myeloid 1 Head & Neck 1 Gynecologic 1 Classical hematology 1 CNS 1

Conditions

Brain Neoplasms 3 Neuroblastoma 1 Neoplasms 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Genetic Predisposition to Disease 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1

Interventions

Temozolomide 19 Bevacizumab 14 Irinotecan 12 Carboplatin 10 Cyclophosphamide 9 Radiosurgery 8 Lomustine 8 Radiotherapy 7 pembrolizumab 6 Vincristine 6 Topotecan 6 Drug Therapy 6 Surgical Procedures, Operative 5 Etoposide 5 Doxorubicin 5 Cisplatin 5 3-Iodobenzylguanidine 5 trametinib 4 Metformin 4 Gemcitabine 4 Dexamethasone 4 Blood Specimen Collection 4 poly ICLC 3 dabrafenib 3 Vorinostat 3 Trastuzumab 3 Therapeutics 3 Radiation 3 Paclitaxel 3 Observation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Interviews as Topic × CNS × Clear all

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡